06/19/2012 - 9:17am

AstraZeneca and Rigel Pharmaceuticals have entered an exclusive worldwide license agreement for the global development and commercialization of an investigational treatment for moderate to severe chronic asthma.

06/18/2012 - 1:33pm

Americans still are forgoing or delaying health care on account of the economy, according to the Kaiser Family Foundation, which recently released its May Health Tracking Poll.

06/18/2012 - 12:35pm

A healthcare company and a drug maker have entered a one-year research partnership to explore diabetes treatment and care.

06/18/2012 - 9:40am

Merck announced that the U.S. District Court for the District of New Jersey ruled against the company in a patent infringement suit against Canada-based drug maker Apotex.

06/18/2012 - 8:50am

A nonprofit global health and disaster relief organization has recognized a drug maker for its commitment to aiding disaster survivors and increasing access to health care around the world.

06/15/2012 - 11:12am

Valeant Pharmaceuticals International has agreed to acquire a specialty oral health company that develops and commercializes products that improve and maintain oral health.

06/15/2012 - 11:08am

GlaxoSmithKline has received regulatory approval from the Food and Drug Administration for a vaccine designed to prevent invasive disease caused by Neisseria meningitidis serogroups C and Y and Haemophilus influenzae type B.

06/14/2012 - 12:47pm

Kadmon Pharmaceuticals earlier this month announced that it has launched a new 600 mg/day dose pack of Ribasphere RibaPak (ribavirin, USP), Kadmon's proprietary ribavirin regimen available in a daily, two-pill compliance package for enhanced therapy adherence.

06/14/2012 - 11:24am

Novo Nordisk and the Juvenile Diabetes Research Foundation on Wednesday announced the creation of a joint research and development team to discover and develop novel immunotherapies to prevent, treat and help cure Type 1 diabetes.